How the FDA sees peptide medicines

A peptide is a short chain of amino acids — the same building blocks as proteins, just smaller. In drug terms they sit in the middle: bigger and more specific than typical pills, smaller and simpler than the large biologic antibodies. That middle ground is exactly why they've become useful medicines.

Not new, and not unregulated

Peptide medicine effectively began with insulin in the 1920s. Since then the FDA has approved on the order of 100 peptide drugs across many conditions — including the GLP-1 and related hormone families — with many more in clinical development. Chemists have learned to modify these molecules to make them more stable and longer-acting, which is why some can be dosed weekly rather than daily.

The distinction that actually matters

Here's the part worth being precise about. An FDA-approved brand product has been reviewed by the FDA for safety, effectiveness, and quality. A compounded medication is prepared by a licensed pharmacy against an individual prescription; it is not FDA-approved, which means the FDA does not review that specific preparation before it's dispensed. Both are real, lawful paths — but they are not the same regulatory thing, and any honest program tells you which one you're getting.

General education, not medical advice, and not a claim about any specific product. Compounded medications are not FDA-approved. Whether any peptide therapy is appropriate for you is decided by a licensed provider after an evaluation.

Related reading

For more, browse the peptide library and read the graded evidence behind each compound — every page tells you plainly whether it is FDA-approved, compounded, in trials, or only in early research.